Analystreport

Keryx Biopharmaceuticals (NASDAQ: KERX) had its "hold" rating re-affirmed by analysts at Maxim Group.

KERYX BIOPHARMACEUTICALS  (KERX) 
Last keryx biopharmaceuticals earnings: 11/8 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.keryx.com/investor-overview